Therapeutic plasma exchange for refractory SLE:A comparison of outcomes between different sub-phenotypes

Soyuoz A., KARADAĞ Ö., Karaagac T., KILIÇ L., Bilgen Ş. Ş., ÖZCEBE O. İ.

EUROPEAN JOURNAL OF RHEUMATOLOGY, vol.5, no.1, pp.32-36, 2018 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 5 Issue: 1
  • Publication Date: 2018
  • Doi Number: 10.5152/eurjrheum.2017.17088
  • Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Page Numbers: pp.32-36
  • Keywords: Therapeutic plasma exchange, Systemic lupus erythematosus, Primary antiphospholipid syndrome, SYSTEMIC-LUPUS-ERYTHEMATOSUS, CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME, APHERESIS, DISEASES, PLASMAPHERESIS, AUTOIMMUNE, GUIDELINES
  • Hacettepe University Affiliated: Yes


Objective: Therapeutic plasma exchange (TPE) offers an alternative therapeutic modality for patients with systemic lupus erythematosus (SLE) and primary antiphospholipid syndrome (APS). However, there is conflicting evidence regarding its efficacy in different sub-phenotypes. This study aimed to investigate the main clinical characteristics and outcomes of patients with different phenotypes of SLE and APS treated with TPE at a tertiary care center.